SMART Trial: Community Stigma Reduction

Overview

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Full Title of Study: “SMART Trial: Reducing Stigma Towards Opioid Use Disorder at the Community Level”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: August 19, 2021

Interventions

  • Behavioral: Opioid Use Disorder Stigma Reduction
    • Billboards with destigmatizing language regarding opioid use disorder placed in the community.

Arms, Groups and Cohorts

  • Experimental: Intervention
    • Participants who live in the Orange Mound community of Memphis. Billboards targeting stigma reduction were posted in the community for one month.
  • No Intervention: Control
    • Participants who live in the Frayser community of Memphis. No billboards (intervention) were placed here.

Clinical Trial Outcome Measures

Primary Measures

  • Stigma score
    • Time Frame: Change from baseline stigma score at 8 weeks
    • Pre- and post-intervention stigma assessments using the Exposure to Drug Users Index, Drug Use Stigmatization Scale, and the Stigma of Drug Users Scale

Participating in This Clinical Trial

Inclusion Criteria

  • Identify as African American or Mixed race – Reside in Frayser or Orange Mound Communities – Access to telephone for follow-up assessment Exclusion Criteria:

  • Unable to understand consent procedures

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Karen Derefinko, PhD
  • Collaborator
    • National Center for Complementary and Integrative Health (NCCIH)
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Karen Derefinko, PhD, Associate Professor – University of Tennessee
  • Overall Official(s)
    • Karen Derefinko, PhD, Principal Investigator, University of Tennessee

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.